Turn-on Fluorescent Dopamine Sensing Based on in Situ Formation of Visible Light Emitting Polydopamine Nanoparticles by Yildirim, A. & Bayindir, M.
Turn-on Fluorescent Dopamine Sensing Based on in Situ Formation
of Visible Light Emitting Polydopamine Nanoparticles
Adem Yildirim†,‡ and Mehmet Bayindir*,†,‡,§
†UNAM-National Nanotechnology Research Center, Bilkent University, 06800 Ankara, Turkey
‡Institute of Materials Science and Nanotechnology, Bilkent University, 06800 Ankara, Turkey
§Department of Physics, Bilkent University, 06800 Ankara, Turkey
*S Supporting Information
ABSTRACT: Dopamine is the principle biomarker for
diseases such as schizophrenia, Huntington’s, and Parkinson’s,
and the need is urgent for rapid and sensitive detection
methods for diagnosis and monitoring of such diseases. In this
Article, we report a turn-on ﬂuorescent method for rapid
dopamine sensing which is based on monitoring the intrinsic
ﬂuorescence of in situ synthesized polydopamine nanoparticles.
The assay uses only a common base and an acid, NaOH and
HCl to initiate and stop the polymerization reaction,
respectively, which makes the assay extremely simple and low cost. First, we studied the in situ optical properties of
polydopamine nanoparticles, for the ﬁrst time, which formed under diﬀerent alkaline conditions in order to determine optimum
experimental parameters. Then, under optimized conditions we demonstrated high sensitivity (40 nM) and excellent selectivity
of the assay. With its good analytical ﬁgures of merit, the described method is very promising for detection of dopamine related
diseases.
Dopamine (DA), a catecholamine neurotransmitter,regulates many biological processes in central nervous,
hormonal, and cardiovascular systems.1,2 Abnormal DA
concentrations in biological ﬂuids (e.g., urine, blood plasma,
and extracellular ﬂuid of the central nervous system) can be
indicator of several diseases such as schizophrenia and
Huntington’s and Parkinson’s diseases.3−5 In this regard,
sensitive and selective measurement of DA levels is important
for diagnosis of these diseases and monitoring of patients.6
Common DA detection methods utilize electrochemical
analysis,7−9 chromatography coupled with spectroscopy10,11
(e.g., high-pressure liquid chromatography (HPLC)-ﬂuores-
cence and gas chromatography/mass spectrometry (GC/MS))
and ﬂuorescent12−16 or colorimetric probes1,17 (e.g., organic
dyes, quantum dots, and gold nanoparticles). These methods,
however, have some limitations. For instance, interference from
uric acid (UA) and ascorbic acid (AA) largely limits selectivity
of electrochemical methods. Chromatographic methods on the
other hand, are time-consuming, labor intensive, and expensive
with complicated procedures. Similarly, synthesis of ﬂuorescent
or colorimetric probes for DA detection involves complicated
and time-consuming procedures.
A straightforward, cost-eﬀective and rapid alternative for DA
detection is measuring the optical absorption of oxidation
product of dopamine under alkaline conditions.18−22 These
assays use only a common base (e.g., NaOH) or other oxidants
(e.g., enzymes) as a reagent, and DA concentration is
determined by simply measuring the optical absorption of the
resulting brownish oxidation product. Unfortunately, the
method demonstrates a poor sensitivity around a few
micromolar. In these oxidation studies, the product is assumed
as a quinone derivative of dopamine.18 However, recent studies
demonstrated that under alkaline conditions the quinone
product is unstable and rapidly polymerized by covalent
attachment and aggregation.23−25 The resulting polymer is
commonly referred to as polydopamine (PDA), which is
structurally very similar to the natural eumelanin polymers.26
Although, the ﬂuorescence property of eumelanins is known for
more than 40 years and there is ongoing research to understand
the interesting optical properties of these materials;27−29 the
ﬂuorescence of PDA is largely unexplored. To our knowledge,
only very recently Zhang et al.30 reported that puriﬁed PDA
nanoparticles are ﬂuorescent and can be used for cellular
imaging.
Here, we explored the intrinsic emission properties of PDA
nanoparticles which were synthesized by oxidizing DA under
diﬀerent conditions and demonstrated that it can be used as
turn-on type ﬂuorescent reporter of DA existence. The
introduced method is based on monitoring the visible light
emission of in situ synthesized PDA nanoparticles, and it is
capable to detect very low DA concentrations (detection limit
is 40 nM). Note that the reached detection limit is 20−750-fold
better than the methods that measure the absorption of
oxidization solution of DA (see the Supporting Information,
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Table S1). Initially, we studied the ﬂuorescence property of
PDA synthesized under diﬀerent basic conditions. We observed
that the emission spectrum of PDA is very dependent on time,
base type, and its concentration. Then, under optimized
conditions, we performed DA sensing experiments. Finally we
showed that the method is very selective to DA, and no
interference from AA or UA is observed.
■ MATERIALS AND METHODS
Materials. Dopamine, ascorbic acid, glucose, urea, sucrose,
aspartic acid, alanine, glycine, lysine, and hydrochloric acid
(37%) were purchased from Sigma-Aldrich (U.S); sodium
hydroxide was purchased from Merck (Germany). All
chemicals were used as purchased.
Oxidization of Dopamine. A volume of 1.8 mL of freshly
prepared dopamine (100 μM) solution in phosphate buﬀered
saline (PBS) (2 mM, pH 7.4) was oxidized by dropwise
addition of 200 μL of Tris base (ﬁnal concentration in the
solution is 10 mM) or NaOH (ﬁnal concentration in the
solutions are 0.5 mM, 10 mM, and 20 mM) stock solutions.
Time dependent evaluation of UV−vis or ﬂuorescence spectra
of the solutions were in situ recorded using UV−vis absorption
(Cary 5000, Varian) and ﬂuorescence (Eclipse, Varian)
spectrophotometers, respectively.
Characterization of Polydopamine Nanoparticles. A
volume of 5.4 mL of dopamine solutions (100 μM) in PBS was
polymerized using 0.6 mL of NaOH (ﬁnal concentration in the
solution is 20 mM) for 3 h. Then the particles were puriﬁed
using membrane dialysis. A volume of 2 μL of puriﬁed particles
dripped on a transmission electron microscopy (TEM) grid,
and morphology of the particles were investigated using a TEM
(Tecnai G2 F30, FEI). For dynamic light scattering (DLS)
measurements, 100 μM of dopamine was polymerized in PBS
for 3 h. Then particles were ﬁltered with a 1 μm syringe ﬁlter,
and their size distribution was measured with Zetasizer
Nanoseries (Malvern Instruments).
Stopping the Oxidization Reaction. In order to stop the
polymerization reaction, excess acid can be added to the
polymerization solution. For instance, 2 mL of dopamine
oxidization solution in which the ﬁnal concentrations of
dopamine and NaOH are 100 μM and 20 mM, respectively,
is stopped using 42 μL of 1 M HCl.
Sensitivity and Selectivity Experiments. Freshly pre-
pared dopamine stock solutions were diluted in PBS to give
ﬁnal volume of 1.8 mL and concentrations ranging from 0.1 to
20 μM. Polymerization reactions were initiated using 200 μL of
NaOH (ﬁnal concentration is 20 mM). After 30 min, reactions
were stopped using 42 μL of 1 M HCl and solutions were
further incubated for 10 min. Then, ﬂuorescence spectra of
solutions were recorded (excitation wavelength is 370 nm). For
selectivity experiments, concentration of all interfering
chemicals (ascorbic acid, uric acid, urea, glucose, sucrose,
aspartic acid, lysine, alanine, and glycine) was 0.1 mM and
other parameters were the same with the sensitivity experi-
ments. All experiments were performed in triplicate.
Absorption Based Assay. The samples were prepared
using the same experimental parameters with the ﬂuorescence
assay. Absorption of DA oxidization solutions (DA concen-
trations were between 0.5 and 20 μM) at 360 nm were
recorded using a UV−vis absorption (Cary 100, Varian)
spectrophotometer.
■ RESULTS AND DISCUSSION
Under alkaline conditions, DA is spontaneously oxidized to its
quinone derivative and then autopolymerized to form PDA
(Scheme 1).23,24 Polymerization of DA solution (1 mM) in
PBS (pH 7.4) was in situ investigated using UV−vis
spectroscopy for 3 h (see the Supporting Information, Figure
S1). After NaOH addition (ﬁnal concentration is 20 mM), a
peak around 350 nm appeared which indicates the quinone
formation24 and its intensity gradually increased for 3 h. The
broad peak around 470 nm shows the intramolecular
cyclization of the quinone derivative24 which is an intermediate
product in the polymerization of DA (see the Supporting
Information, inset of Figure S1).23 After 10 min, this broad
peak disappeared and absorption at all wavelengths between
400 and 700 nm increased gradually, which shows the
formation of PDA.24 In order to characterize the PDA
nanoparticles formed after 3 h of oxidization reaction, we
polymerized 100 μM DA using 20 mM NaOH. Particle size
distribution of PDA nanoparticles is given in Figure 1, which
shows the broad size distribution of particles with diameters
ranging from a few nanometers to hundreds of nanometers.
Figure 1 inset shows the TEM image of 3 h oxidized PDA
particles. PDA nanoparticles were irregular in shape and have
broad particle size distribution which is in accordance with DLS
results.
Scheme 1. Schematic Representation of Fluorescent PDA
Nanoparticle Formation
Figure 1. Particle size distribution of PDA nanoparticles. The graph
shows the particle size distribution of PDA nanoparticles which were
prepared after oxidization of 100 μM DA solution for 3 h in the
presence of 20 mM NaOH. Inset shows the TEM images of the
puriﬁed DA oxidization solution showing the polydisperse and
irregularly shaped PDA nanoparticles.
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The resulting PDA nanoparticles are intrinsically ﬂuorescent
(will be discussed in detail below). Initially, we explored the
eﬀect of diﬀerent oxidation conditions on the ﬂuorescence of
oxidation product of DA (i.e., PDA nanoparticles) in order to
determine optimum experimental conditions for DA sensing.
We compared two bases that are commonly applied in DA
oxidization;18,23 Tris base and NaOH at the same pH and
molarity. We measured the in situ ﬂuorescence of 100 μM DA
which is oxidized under diﬀerent basic conditions for 1 h and
compared the ﬂuorescence intensities at 510 nm at diﬀerent
time intervals. The results are presented in Figure 2 and Figure
S2 (Supporting Information). At the same pH value (9.6), Tris
is more eﬀective than NaOH in terms of generating ﬂuorescent
PDA nanoparticles. On the other hand, at the same molarity
(10 mM), NaOH is almost 2 times more eﬀective than Tris
base. Also, we explored ﬂuorescence of the polymerization
solution at diﬀerent NaOH concentrations, and we selected 20
mM as optimal for the sensing experiments. Therefore, we used
20 mM NaOH to oxidize DA in the rest of the study.
The ﬂuorescence spectra of synthesized PDA nanoparticles
after 3 h of oxidization, which were prepared using 100 μM DA,
is given in Figure 3a. We observed that ﬂuorescence behavior of
the resulting PDA nanoparticles is very similar to eumelanin
polymers in which the ﬂuorescence spectrum is excitation
wavelength dependent and can be tuned in the whole visible
spectra.28 With the increasing excitation wavelength, the
emission maximum of the PDA nanoparticle solution shifts to
the longer wavelengths (Figure 3b). Also, emission intensity is
excitation wavelength dependent; it initially enhances with
increasing wavelengths and then started to decrease gradually.
The maximum emission intensities were recorded between the
excitation wavelengths of 350 and 400 nm. Therefore, we
selected 370 nm as the excitation wavelength for DA sensing
experiments.
Figure 3c shows the ﬂuorescence spectra of 100 μM DA
solution recorded at diﬀerent time intervals up to 6 h. After
NaOH addition, two emission peaks immediately formed at
around 470 and 530 nm, respectively. In the ﬁrst 30 min,
intensities of the both peaks gradually increased. Interestingly,
after 30 min the intensity of the peak around 530 nm started to
decrease and it completely disappeared in 2 h. The peak
intensity around 470 nm, on the other hand, decreased slightly
between 30 and 60 min but after this point it started to increase
again. After 6 h, only an intense peak around 470 nm was
observed. The peak around 530 nm may correspond to an
intermediate product in the polymerization reaction, which is
formed and consumed in 1 h. We believe that in situ
ﬂuorescence measurements of the DA oxidation solution can
give information about the structure of PDA, which is still not
completely identiﬁed;31 however, it is beyond the scope of this
study. Figure 3d shows the emission intensity maxima of the
same solution during polymerization. In the ﬁrst minutes of
polymerization, the ﬂuorescence intensity sharply increased,
after about 30 min it started to decrease, and after 90 min it
began to raise again. Accordingly, we selected 30 min as the
incubation time for sensing experiments.
The time dependent ﬂuorescence spectrum of the DA
oxidization solution can be a source of error in the analytical
measurements. To overcome this problem and obtain stable
emission characteristic over time, we added excess HCl to DA
solutions after a certain time of oxidization and stopped the
polymerization reaction by making the solution acidic. Figure
4a shows the ﬂuorescence spectra of a DA oxidation solution
(100 μM) before and after HCl addition. In the ﬁrst 15 min,
emission intensity increases gradually as expected. After HCl
addition, the ﬂuorescence spectrum of the solution shifted to
shorter wavelengths and becomes very stable over time. In
Figure 4b, the emission intensity at 510 nm was plotted as a
function of time. After HCl addition intensity at 510 nm
increased slightly and then it was almost constant for at least 45
min.
In order to evaluate the performance of the assay, we tested
diﬀerent concentrations of DA between 0.1 and 20 μM with the
assay. First, oxidation of dopamine solutions at diﬀerent
concentrations in PBS was initiated using NaOH (20 mM)
and after 30 min excess HCl was added to stop the reaction.
Then, ﬂuorescence spectra of the DA solutions were recorded
(Figure 5a). As expected with the increasing DA concentration,
ﬂuorescence of the solution becomes brighter. Figure 5b shows
the ﬂuorescence intensities at 510 nm as a function of DA
concentration. We observed that the response of the assay is
Figure 2. Time dependent ﬂuorescence intensity at 510 nm of 100 μM
DA solutions, which were oxidized at diﬀerent basic conditions.
Figure 3. Emission properties of PDA nanoparticles: (a) excitation
wavelength dependent ﬂuorescence spectra of PDA nanoparticles, (b)
change of the ﬂuorescence intensity maxima and wavelength of PDA
nanoparticle solution as a function of excitation wavelength, (c) time
dependent ﬂuorescence spectra of 100 μM DA solution oxidized using
20 mM NaOH, and (d) ﬂuorescence intensity maximum change of the
same solution over time.
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highly linear (R2 = 0.996) in the studied concentration region.
Relative standard deviations (RSD) of three separate experi-
ments in Figure 5b are between 0.2% and 2.4% indicating the
good reproducibility of the sensor response. Using this
calibration line, we calculated limit of detection (LOD) and
limit of qualiﬁcation (LOQ) values of the assay as 40 nM and
120 nM, respectively. The achieved LOD and LOQ values of
our ﬂuorescence based assay is much better than absorption
based methods (see the Supporting Information, Table S1)
which typically have LOD and LOQ values above the
miromolar level. In addition, to directly compare the perform-
ance of our ﬂuorescence assay with the absorption based
method, we measured the absorption of DA solutions which
were oxidized using the same conditions with ﬂuorescence
experiments. We observed that for the concentrations above 1
μM there is a statistically signiﬁcant diﬀerence in the absorption
value between blank and DA solutions (see the Supporting
Information, Figure S3). For the concentrations below 1 μM,
the absorption assay could not detect the presence of DA,
which is also in accordance with the previous reports.18−22
Lastly, we tested the selectivity of the assay using possible
interfering chemicals such as AA, UA, amino acids, and sugars.
The concentration of interfering substances is 100 μM. None of
the tested chemicals produced a ﬂuorescence signal even at this
high concentration (Figure 6). To further demonstrate the
selectivity of the method, we measured the ﬂuorescence of 10
μM DA oxidization solution in the presence of mixture of all of
interfering chemicals that used in this study (concentration of
interfering chemicals was 100 μM). Presence of these chemicals
in the DA assay has no eﬀect on the ﬂuorescence response
(Figure 6). The observed excellent selectivity over DA of our
assay is due to its speciﬁc response against PDA nanoparticle
formation.
■ CONCLUSION
In conclusion, we developed a facile assay for detection of DA,
which is based on measuring the ﬂuorescence signal of the
oxidation product of the DA. In order to determine optimum
conditions for DA detection, we initiated the polymerization of
DA at diﬀerent oxidation conditions and recorded time
Figure 4. Stopping the polymerization reaction of DA using HCl: (a)
ﬂuorescence spectra of 100 μM DA, which is oxidized using 20 mM
NaOH and after 15 min excess HCl was added; (b) ﬂuorescence
intensity at 510 nm change with time before and after HCl addition.
Figure 5. Sensitivity of the dopamine assay. (a) Fluorescence response
of the assay against diﬀerent concentrations of DA. (b) Assay response
as a function of DA concentration which indicates the good linearity of
the sensor in the studied region.
Figure 6. Selectivity of the dopamine assay. DA concentration is 10
μM and concentration of other substances is 100 μM. Fluorescence
response was only observed for DA indicating the excellent selectivity
of the assay (DA, dopamine; AA, ascorbic acid; UA, uric acid; Glc,
glucose; Suc, sucrose; Asp, aspartic acid; Lys, lysine; Ala, alanine; Gly,
glycine; Mix, mixture of all interfering chemicals).
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dependent emission spectra of these solutions. Accordingly, we
achieved a DA detection limit of as low as 40 nM. In addition,
we did not observe any interference from AA and UA and as
well as many amino acids and sugars. Compared with other DA
detection methods, our assay is extremely simple and low cost,
which make the method very promising for detection of DA
deﬁciency related diseases.
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